IL29

IL29

A gene on chromosome 19q13.13 that encodes interleukin-29, an immunomodulatory cytokine which upregulates MHC class-I antigen expression. It has potent antiviral activity and has antitumour activity. IL29 is a ligand for the heterodimeric class-II cytokine receptor composed of IL10RB and IL28RA, which is thought to act via the JAK-STAT pathway.
References in periodicals archive ?
Primer sequences of SLC15A3, HSV-1 gD gene, IFN-[beta], IL29, and [beta]-actin as listed in Table S2.
SLC15A3 Participates in Signaling Pathways That Activate IFN[beta] and IL29 by HSV-1.
We found cotransfection of SLC15A3 and MAVS significantly enhanced IFN[beta] and IL29 induction upon intracellular poly(I:C) stimulation (Figure 5(b)), and cotransfection of SLC15A3 and STING also significantly enhanced IFN[beta] and IL29 induction upon intracellular HSV60 stimulation (Figure 5(c)), suggesting that SLC38A5 augments MAVS- and STING-mediated IFN responses.
The induction of IFN[beta] and IL29 by poly(I:C), poly(dA:dT), and 2'3'-cGAMP was significantly reduced in cells transfected with SLC15A3 siRNA as compared to cells transfected with scrambled siRNA (Figures 6(b) and 6(c)).
Caption: Figure 4: SLC15A3 enhances HSV-1-mediated IL29 and IFN[beta] induction.
LQ11/pLAU53, LQ12/pLAU53, LQ13/pLAU53, LQ14/pLAU53, and LQ15/pLAU53 strains were generated by P1transduction of (tetO) [sub]240 -Gm and (lacO) [sub]240 -Km cassettes from strains IL2 and IL29. Fluorescence microscopy was performed to observe localization pattern of fluorescently-labeled origin and terminus foci in wild-type and mutant cells.
The strain IL29 has the kanamycin resistant lacO repeat cassette localized near the dif site (1803 kb position).